Linda Kubat
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 11, 2024
Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics.
Journal: Frontiers in oncology
Published: November 05, 2022
B-cell lymphoma-extra large is a promising drug target in Merkel cell carcinoma.
Journal: The British journal of dermatology
Published: August 24, 2022
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: December 11, 2021
Persister state-directed transitioning and vulnerability in melanoma.
Journal: Nature communications
Published: February 19, 2021
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes.
Journal: Cancer immunology, immunotherapy : CII
Published: May 05, 2020
UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines.
Journal: Journal of cancer research and clinical oncology
Published: December 18, 2019
Conversion of Sox2-dependent Merkel cell carcinoma to a differentiated neuron-like phenotype by T antigen inhibition.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 19, 2019
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma.
Journal: The Journal of investigative dermatology
Published: September 17, 2019
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 09, 2019
Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.
Journal: Blood
Published: December 01, 2018
Last Updated: 09/26/2026